| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | inositol 1,4,5-trisphosphate-gated calcium channel activity | 1.77e-08 | 3 | 53 | 3 | GO:0005220 | |
| GeneOntologyMolecularFunction | inositol 1,4,5 trisphosphate binding | 6.30e-06 | 14 | 53 | 3 | GO:0070679 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.40e-05 | 18 | 53 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 7.53e-05 | 31 | 53 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 9.11e-05 | 33 | 53 | 3 | GO:0005217 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.81e-04 | 129 | 53 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.90e-04 | 151 | 53 | 4 | GO:0015085 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 8.88e-06 | 53 | 51 | 4 | GO:0071320 | |
| GeneOntologyBiologicalProcess | response to purine-containing compound | 5.54e-05 | 166 | 51 | 5 | GO:0014074 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.43e-06 | 9 | 55 | 3 | GO:0031095 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.80e-06 | 11 | 55 | 3 | GO:0031094 | |
| GeneOntologyCellularComponent | IgE immunoglobulin complex | 1.01e-04 | 6 | 55 | 2 | GO:0071742 | |
| GeneOntologyCellularComponent | spectrin-associated cytoskeleton | 2.42e-04 | 9 | 55 | 2 | GO:0014731 | |
| GeneOntologyCellularComponent | spectrin | 2.42e-04 | 9 | 55 | 2 | GO:0008091 | |
| Domain | InsP3_rcpt-bd | 2.16e-08 | 3 | 53 | 3 | IPR000493 | |
| Domain | RIH_assoc | 4.29e-07 | 6 | 53 | 3 | PF08454 | |
| Domain | RIH_assoc-dom | 4.29e-07 | 6 | 53 | 3 | IPR013662 | |
| Domain | RIH_dom | 4.29e-07 | 6 | 53 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 4.29e-07 | 6 | 53 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 4.29e-07 | 6 | 53 | 3 | IPR015925 | |
| Domain | - | 4.29e-07 | 6 | 53 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 4.29e-07 | 6 | 53 | 3 | PF01365 | |
| Domain | Ins145_P3_rec | 4.29e-07 | 6 | 53 | 3 | PF08709 | |
| Domain | MIR | 2.55e-06 | 10 | 53 | 3 | PS50919 | |
| Domain | MIR | 2.55e-06 | 10 | 53 | 3 | PF02815 | |
| Domain | MIR | 2.55e-06 | 10 | 53 | 3 | SM00472 | |
| Domain | MIR_motif | 2.55e-06 | 10 | 53 | 3 | IPR016093 | |
| Domain | NPIP | 7.68e-06 | 14 | 53 | 3 | IPR009443 | |
| Domain | EMI_domain | 1.18e-05 | 16 | 53 | 3 | IPR011489 | |
| Domain | EMI | 1.43e-05 | 17 | 53 | 3 | PS51041 | |
| Domain | Spectrin_bsu | 4.72e-05 | 4 | 53 | 2 | IPR016343 | |
| Domain | Ion_trans_dom | 3.06e-04 | 114 | 53 | 4 | IPR005821 | |
| Domain | Ion_trans | 3.06e-04 | 114 | 53 | 4 | PF00520 | |
| Domain | EMI | 3.50e-04 | 10 | 53 | 2 | PF07546 | |
| Domain | RCC1 | 1.45e-03 | 20 | 53 | 2 | PF00415 | |
| Domain | RCC1_1 | 1.60e-03 | 21 | 53 | 2 | PS00625 | |
| Domain | RCC1_2 | 1.60e-03 | 21 | 53 | 2 | PS00626 | |
| Domain | RCC1_3 | 1.60e-03 | 21 | 53 | 2 | PS50012 | |
| Domain | Reg_chr_condens | 1.76e-03 | 22 | 53 | 2 | IPR000408 | |
| Domain | - | 1.76e-03 | 22 | 53 | 2 | 2.130.10.30 | |
| Domain | Actinin_actin-bd_CS | 1.92e-03 | 23 | 53 | 2 | IPR001589 | |
| Domain | Spectrin | 1.92e-03 | 23 | 53 | 2 | PF00435 | |
| Domain | ACTININ_2 | 1.92e-03 | 23 | 53 | 2 | PS00020 | |
| Domain | ACTININ_1 | 1.92e-03 | 23 | 53 | 2 | PS00019 | |
| Domain | RCC1/BLIP-II | 1.92e-03 | 23 | 53 | 2 | IPR009091 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PF00632 | |
| Domain | HECTc | 2.65e-03 | 27 | 53 | 2 | SM00119 | |
| Domain | HECT_dom | 2.65e-03 | 27 | 53 | 2 | IPR000569 | |
| Domain | HECT | 2.65e-03 | 27 | 53 | 2 | PS50237 | |
| Domain | ARM-type_fold | 2.69e-03 | 339 | 53 | 5 | IPR016024 | |
| Domain | Spectrin_repeat | 3.05e-03 | 29 | 53 | 2 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 3.71e-03 | 32 | 53 | 2 | IPR018159 | |
| Domain | SPEC | 3.71e-03 | 32 | 53 | 2 | SM00150 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY | 2.27e-07 | 5 | 41 | 3 | M49000 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY | 4.54e-07 | 6 | 41 | 3 | M47960 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 1.03e-06 | 27 | 41 | 4 | M12123 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY | 1.90e-06 | 9 | 41 | 3 | M47852 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 2.70e-06 | 10 | 41 | 3 | M47661 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY | 3.71e-06 | 11 | 41 | 3 | M49033 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION | 3.71e-06 | 11 | 41 | 3 | M27466 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY | 6.40e-06 | 13 | 41 | 3 | M47656 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 6.40e-06 | 13 | 41 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 6.40e-06 | 13 | 41 | 3 | M47751 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 6.40e-06 | 13 | 41 | 3 | MM14553 | |
| Pathway | SIG_CHEMOTAXIS | 8.42e-06 | 45 | 41 | 4 | M5193 | |
| Pathway | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | 1.25e-05 | 16 | 41 | 3 | M26945 | |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | 1.49e-05 | 186 | 41 | 6 | M27175 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 2.14e-05 | 19 | 41 | 3 | M27423 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.14e-05 | 19 | 41 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY | 2.14e-05 | 19 | 41 | 3 | M47733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 2.52e-05 | 20 | 41 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 2.93e-05 | 21 | 41 | 3 | M47689 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.38e-05 | 22 | 41 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.38e-05 | 22 | 41 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.88e-05 | 23 | 41 | 3 | M47676 | |
| Pathway | KEGG_LONG_TERM_DEPRESSION | 4.91e-05 | 70 | 41 | 4 | M8232 | |
| Pathway | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | 5.02e-05 | 25 | 41 | 3 | MM14511 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.36e-05 | 27 | 41 | 3 | MM15053 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 6.79e-05 | 76 | 41 | 4 | M9052 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.11e-05 | 28 | 41 | 3 | M924 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 1.07e-04 | 32 | 41 | 3 | MM14983 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.10e-04 | 86 | 41 | 4 | M27206 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 1.53e-04 | 36 | 41 | 3 | M1315 | |
| Pathway | WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION | 1.53e-04 | 36 | 41 | 3 | M39831 | |
| Pathway | REACTOME_CLEC7A_DECTIN_1_SIGNALING | 1.97e-04 | 100 | 41 | 4 | M27467 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 2.05e-04 | 101 | 41 | 4 | M1979 | |
| Pathway | REACTOME_DAG_AND_IP3_SIGNALING | 2.25e-04 | 41 | 41 | 3 | M512 | |
| Pathway | REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION | 2.42e-04 | 42 | 41 | 3 | M791 | |
| Pathway | WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS | 2.78e-04 | 44 | 41 | 3 | M39845 | |
| Pathway | SIG_BCR_SIGNALING_PATHWAY | 3.18e-04 | 46 | 41 | 3 | M8626 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 3.37e-04 | 115 | 41 | 4 | M9387 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.66e-04 | 10 | 41 | 2 | MM15112 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY | 4.07e-04 | 50 | 41 | 3 | M47951 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 4.84e-04 | 53 | 41 | 3 | MM15716 | |
| Pathway | REACTOME_G_PROTEIN_MEDIATED_EVENTS | 5.11e-04 | 54 | 41 | 3 | M26911 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.11e-04 | 54 | 41 | 3 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.11e-04 | 54 | 41 | 3 | MM15202 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 5.39e-04 | 55 | 41 | 3 | M47952 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 5.53e-04 | 131 | 41 | 4 | MM15717 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 7.10e-04 | 140 | 41 | 4 | M27484 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 7.31e-04 | 61 | 41 | 3 | MM15071 | |
| Pathway | REACTOME_CA2_PATHWAY | 7.67e-04 | 62 | 41 | 3 | M27321 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.03e-04 | 63 | 41 | 3 | M11187 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 8.30e-04 | 146 | 41 | 4 | M27288 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 8.49e-04 | 257 | 41 | 5 | MM15454 | |
| Pathway | REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION | 9.10e-04 | 261 | 41 | 5 | M1077 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.09e-03 | 70 | 41 | 3 | M3115 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.18e-03 | 72 | 41 | 3 | MM14631 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.28e-03 | 74 | 41 | 3 | M48080 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 1.28e-03 | 74 | 41 | 3 | MM15962 | |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | 1.34e-03 | 166 | 41 | 4 | M608 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.39e-03 | 76 | 41 | 3 | MM15051 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.49e-03 | 78 | 41 | 3 | M1921 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 1.72e-03 | 82 | 41 | 3 | M27110 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.73e-03 | 178 | 41 | 4 | M2890 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 1.98e-03 | 86 | 41 | 3 | M601 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 1.98e-03 | 86 | 41 | 3 | M916 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.03e-03 | 313 | 41 | 5 | M27867 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 2.08e-03 | 464 | 41 | 6 | M27547 | |
| Pathway | REACTOME_OPIOID_SIGNALLING | 2.25e-03 | 90 | 41 | 3 | M6467 | |
| Pathway | KEGG_GAP_JUNCTION | 2.25e-03 | 90 | 41 | 3 | M4013 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 2.32e-03 | 828 | 41 | 8 | M1058 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 2.56e-03 | 330 | 41 | 5 | M7847 | |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | 2.63e-03 | 95 | 41 | 3 | M29842 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 2.77e-03 | 27 | 41 | 2 | M26943 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 2.79e-03 | 203 | 41 | 4 | M5485 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.21e-03 | 102 | 41 | 3 | M27648 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 3.30e-03 | 103 | 41 | 3 | MM15196 | |
| Pathway | REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS | 3.54e-03 | 217 | 41 | 4 | M18437 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 3.58e-03 | 106 | 41 | 3 | M27077 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.64e-03 | 31 | 41 | 2 | M877 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 3.77e-03 | 108 | 41 | 3 | M17034 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 3.97e-03 | 110 | 41 | 3 | MM15350 | |
| Pathway | WP_BDNFTRKB_SIGNALING | 4.12e-03 | 33 | 41 | 2 | M39532 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 4.12e-03 | 33 | 41 | 2 | M39745 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | 4.28e-03 | 113 | 41 | 3 | M16817 | |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | 4.30e-03 | 719 | 41 | 7 | MM14540 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.40e-03 | 1128 | 41 | 9 | M1036 | |
| Pathway | WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS | 4.95e-03 | 119 | 41 | 3 | M48309 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 10874040 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 9808793 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 20395455 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17437169 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 18194433 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 18547250 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 36350267 | ||
| Pubmed | IP3 receptors regulate vascular smooth muscle contractility and hypertension. | 4.17e-09 | 3 | 57 | 3 | 27777977 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 11413485 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 26009177 | ||
| Pubmed | Differential inositol 1,4,5-trisphosphate receptor signaling in a neuronal cell line. | 4.17e-09 | 3 | 57 | 3 | 17581770 | |
| Pubmed | Predominant role of type 1 IP3 receptor in aortic vascular muscle contraction. | 4.17e-09 | 3 | 57 | 3 | 18241669 | |
| Pubmed | Receptor-activated single channels in intact human platelets. | 4.17e-09 | 3 | 57 | 3 | 1693919 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 19068129 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 23955339 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 31979185 | ||
| Pubmed | Tsg101 regulates PI(4,5)P2/Ca(2+) signaling for HIV-1 Gag assembly. | 4.17e-09 | 3 | 57 | 3 | 24904548 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17327232 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 16014380 | ||
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 17890015 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptors and human left ventricular myocytes. | 4.17e-09 | 3 | 57 | 3 | 23983250 | |
| Pubmed | Differential distribution of inositol trisphosphate receptor isoforms in mouse oocytes. | 4.17e-09 | 3 | 57 | 3 | 9858485 | |
| Pubmed | 4.17e-09 | 3 | 57 | 3 | 20427533 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 25215520 | ||
| Pubmed | Inositol 1, 4, 5-trisphosphate receptor interacts with the SNARE domain of syntaxin 1B. | 1.67e-08 | 4 | 57 | 3 | 21424589 | |
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 28615414 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 10828023 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 28419336 | ||
| Pubmed | 1.67e-08 | 4 | 57 | 3 | 11163362 | ||
| Pubmed | IP3R-mediated Ca2+ signaling controls B cell proliferation through metabolic reprogramming. | 1.67e-08 | 4 | 57 | 3 | 35494252 | |
| Pubmed | InsP₃receptors and Orai channels in pancreatic acinar cells: co-localization and its consequences. | 4.16e-08 | 5 | 57 | 3 | 21568942 | |
| Pubmed | 8.32e-08 | 6 | 57 | 3 | 23463619 | ||
| Pubmed | Sprouty2 regulates PI(4,5)P2/Ca2+ signaling and HIV-1 Gag release. | 8.32e-08 | 6 | 57 | 3 | 21762810 | |
| Pubmed | 8.32e-08 | 6 | 57 | 3 | 20519450 | ||
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 8.32e-08 | 6 | 57 | 3 | 25966694 | |
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 8.32e-08 | 6 | 57 | 3 | 16844763 | |
| Pubmed | 1.45e-07 | 7 | 57 | 3 | 11860456 | ||
| Pubmed | Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes. | 1.45e-07 | 7 | 57 | 3 | 22495310 | |
| Pubmed | 3.48e-07 | 9 | 57 | 3 | 25737585 | ||
| Pubmed | Type 1 and 3 inositol trisphosphate receptors are required for extra-embryonic vascular development. | 6.82e-07 | 11 | 57 | 3 | 27514653 | |
| Pubmed | 1.50e-06 | 14 | 57 | 3 | 34630045 | ||
| Pubmed | Synergistic Signaling by Light and Acetylcholine in Mouse Iris Sphincter Muscle. | 1.87e-06 | 15 | 57 | 3 | 28578927 | |
| Pubmed | Isoform diversity of the inositol trisphosphate receptor in cell types of mouse origin. | 2.64e-06 | 2 | 57 | 2 | 9065779 | |
| Pubmed | Expression of IP3 receptor isoforms at the nodes of Ranvier in rat sciatic nerve. | 2.64e-06 | 2 | 57 | 2 | 17496801 | |
| Pubmed | Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. | 2.64e-06 | 2 | 57 | 2 | 8663526 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15890645 | ||
| Pubmed | Mice lacking inositol 1,4,5-trisphosphate receptors exhibit dry eye. | 2.64e-06 | 2 | 57 | 2 | 24901844 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 33854148 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 18708078 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15201137 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19528657 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8063813 | ||
| Pubmed | Cloning and characterization of human type 2 and type 3 inositol 1,4,5-trisphosphate receptors. | 2.64e-06 | 2 | 57 | 2 | 8081734 | |
| Pubmed | Sulphide signalling potentiates apoptosis through the up-regulation of IP3 receptor types 1 and 2. | 2.64e-06 | 2 | 57 | 2 | 23582047 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 1374893 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 32952549 | ||
| Pubmed | IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. | 2.64e-06 | 2 | 57 | 2 | 16195467 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15632133 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20813840 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 15713744 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 7559486 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 20843799 | ||
| Pubmed | Type 1 and 2 IP3 receptors respond differently to catecholamines and stress. | 2.64e-06 | 2 | 57 | 2 | 19120126 | |
| Pubmed | Distinct roles of inositol 1,4,5-trisphosphate receptor types 1 and 3 in Ca2+ signaling. | 2.64e-06 | 2 | 57 | 2 | 14707143 | |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.35e-06 | 18 | 57 | 3 | 12119179 | |
| Pubmed | 6.29e-06 | 22 | 57 | 3 | 11696558 | ||
| Pubmed | Rescue of calcineurin Aα(-/-) mice reveals a novel role for the α isoform in the salivary gland. | 7.91e-06 | 3 | 57 | 2 | 21435446 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 11294830 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 22992961 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 12032348 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 32320395 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 12421829 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 23223241 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 16286649 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 8479293 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 18250332 | ||
| Pubmed | β spectrin-dependent and domain specific mechanisms for Na+ channel clustering. | 7.91e-06 | 3 | 57 | 2 | 32425157 | |
| Pubmed | Developmental expression of brain beta-spectrin isoform messenger RNAs. | 7.91e-06 | 3 | 57 | 2 | 1467942 | |
| Pubmed | 8.24e-06 | 24 | 57 | 3 | 10843712 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.12e-05 | 1105 | 57 | 10 | 35748872 | |
| Pubmed | 1.48e-05 | 29 | 57 | 3 | 32123907 | ||
| Pubmed | Abnormal taste perception in mice lacking the type 3 inositol 1,4,5-trisphosphate receptor. | 1.58e-05 | 4 | 57 | 2 | 17925404 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 21818117 | ||
| Pubmed | IRE1α/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis. | 1.58e-05 | 4 | 57 | 2 | 26193638 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 21566095 | ||
| Pubmed | Remarkable homology among the internal repeats of erythroid and nonerythroid spectrin. | 1.58e-05 | 4 | 57 | 2 | 3862089 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 21412925 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 23884412 | ||
| Pubmed | Regulation of InsP3 receptor activity by neuronal Ca2+-binding proteins. | 1.58e-05 | 4 | 57 | 2 | 14685260 | |
| Pubmed | Ins(1,4,5)P3 receptor-mediated Ca2+ signaling and autophagy induction are interrelated. | 1.58e-05 | 4 | 57 | 2 | 22082873 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 19120137 | ||
| Pubmed | Spectrin alpha II and beta II isoforms interact with high affinity at the tetramerization site. | 1.58e-05 | 4 | 57 | 2 | 12820899 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 11524429 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 8081710 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 15613488 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 11782428 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 19706527 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 2.63e-05 | 5 | 57 | 2 | 29720258 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 21480213 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 21436055 | ||
| Interaction | IRAG1 interactions | 6.48e-06 | 14 | 54 | 3 | int:IRAG1 | |
| Interaction | TESPA1 interactions | 9.94e-06 | 16 | 54 | 3 | int:TESPA1 | |
| Interaction | TRPC4 interactions | 3.10e-05 | 23 | 54 | 3 | int:TRPC4 | |
| Interaction | RASEF interactions | 4.01e-05 | 25 | 54 | 3 | int:RASEF | |
| Interaction | BBOX1 interactions | 6.32e-05 | 29 | 54 | 3 | int:BBOX1 | |
| Interaction | TRPC1 interactions | 6.32e-05 | 29 | 54 | 3 | int:TRPC1 | |
| Interaction | TRPC2 interactions | 7.01e-05 | 5 | 54 | 2 | int:TRPC2 | |
| Cytoband | 22q12.2 | 5.33e-05 | 58 | 57 | 3 | 22q12.2 | |
| Cytoband | 15q22 | 6.02e-04 | 29 | 57 | 2 | 15q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 6.07e-04 | 132 | 57 | 3 | chr15q22 | |
| GeneFamily | Inositol 1,4,5-triphosphate receptors|Protein phosphatase 1 regulatory subunits | 1.00e-08 | 3 | 40 | 3 | 297 | |
| GeneFamily | EF-hand domain containing|Spectrins | 9.95e-05 | 7 | 40 | 2 | 1113 | |
| GeneFamily | EMI domain containing | 9.95e-05 | 7 | 40 | 2 | 540 | |
| Coexpression | GSE27786_LSK_VS_MONO_MAC_DN | 4.33e-06 | 200 | 56 | 6 | M4765 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.70e-06 | 156 | 57 | 5 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.24e-06 | 188 | 57 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 4.58e-06 | 191 | 57 | 5 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-06 | 194 | 57 | 5 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.07e-06 | 195 | 57 | 5 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.32e-06 | 197 | 57 | 5 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.32e-06 | 197 | 57 | 5 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid-Megakaryocyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.73e-06 | 200 | 57 | 5 | 0d76b006d8e8b32174e65e400acd0674354b962c | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.73e-06 | 200 | 57 | 5 | cc8368665bc6bb7c4f39632ccff07ceaa98a7b65 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.19e-05 | 151 | 57 | 4 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_C-8|TCGA-Thymus / Sample_Type by Project: Shred V9 | 4.64e-05 | 155 | 57 | 4 | 00eef9f93a753a1fe1ab5fd8dae026e7be556cde | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-B_lymphocytic-memory_B_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.64e-05 | 155 | 57 | 4 | d336559092563b0d7776eef873f1d2759aca45f7 | |
| ToppCell | PBMC-Control-cDC_1|Control / Compartment, Disease Groups and Clusters | 4.76e-05 | 156 | 57 | 4 | 9b6c5bcac516a62bcc1f5be32ffa8c92735ef0bc | |
| ToppCell | FLU-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.13e-05 | 159 | 57 | 4 | 97c8e16a7ac10ebba96daee97f9fb1d4a404f23b | |
| ToppCell | FLU-Healthy-1|FLU / Virus stimulation, Condition and Cluster | 5.13e-05 | 159 | 57 | 4 | fe2a9f79b058e89214256e736f6e266830cdfa28 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.51e-05 | 162 | 57 | 4 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 165 | 57 | 4 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.96e-05 | 172 | 57 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 173 | 57 | 4 | 3059325901b1e5e12a1a91183f14267288b2f600 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 7.11e-05 | 173 | 57 | 4 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 173 | 57 | 4 | 36c8338463ee4cc432f568728d55989360f9a68d | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.44e-05 | 175 | 57 | 4 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | 3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 7.60e-05 | 176 | 57 | 4 | b9da3deaf62622d47eb30b6be7548253eee95597 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.60e-05 | 176 | 57 | 4 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.77e-05 | 177 | 57 | 4 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.12e-05 | 179 | 57 | 4 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.66e-05 | 182 | 57 | 4 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.66e-05 | 182 | 57 | 4 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 9.03e-05 | 184 | 57 | 4 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|Mesenchymal_cells / Lineage and Cell class | 9.03e-05 | 184 | 57 | 4 | 83987abaedc26e6da477bc70d65e10b1ab1aea60 | |
| ToppCell | Tuft|World / Class top | 9.41e-05 | 186 | 57 | 4 | f4d83f15ab7b49c0920a322cd832413ece7c9948 | |
| ToppCell | Tuft-tuft-2|World / Class top | 9.61e-05 | 187 | 57 | 4 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | Fetal_29-31_weeks-Immune-enucleated_erythrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 189 | 57 | 4 | 1900e574870fc647bfa11c732a72f3d38aab717c | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | ff7874cc005760a8f3b2e8072fbe418b6bfacaa8 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.04e-04 | 191 | 57 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 191 | 57 | 4 | 96ff4cfbdcaec4b8568f9482d732dddd399121d3 | |
| ToppCell | facs-Bladder-nan-18m-Epithelial-bladder_urothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 192 | 57 | 4 | 18546b4d5e39aafa97186104d47cfda02eb5f4b5 | |
| ToppCell | CV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 1.06e-04 | 192 | 57 | 4 | 2a2052b44e8f679ef484f03ba4fb37b0ec841b88 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.06e-04 | 192 | 57 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 192 | 57 | 4 | 88472b99970ba0decbf87164fc241a1c77b3b389 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 193 | 57 | 4 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 193 | 57 | 4 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 193 | 57 | 4 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 194 | 57 | 4 | fb234d97191c95b7880280c6e4ed5df124ffb0e1 | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.11e-04 | 194 | 57 | 4 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 1.13e-04 | 195 | 57 | 4 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | B_cells-ISG-high_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.13e-04 | 195 | 57 | 4 | b64d9e1a8834401b4dc501566546647754ae21fc | |
| ToppCell | (01)_IL1RL1+-(1)_GFP|(01)_IL1RL1+ / shred by cell type by condition | 1.15e-04 | 196 | 57 | 4 | b598b1112242534e139318012b257ed3cb09da83 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.15e-04 | 196 | 57 | 4 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 1.15e-04 | 196 | 57 | 4 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | metastatic_Brain-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.15e-04 | 196 | 57 | 4 | d1a2768a1d0e5928fbd9debb7dcd7436134e09f6 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.15e-04 | 196 | 57 | 4 | 541b1fcf509e362f6f48720046cb5378aaf7c591 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 1.17e-04 | 197 | 57 | 4 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 197 | 57 | 4 | 72a29a796b253a35c8772117a800d2a72fd89a3f | |
| ToppCell | severe-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.17e-04 | 197 | 57 | 4 | c8a90d82170cf20e14aebecddcf7cc0ca56cda87 | |
| ToppCell | CD8+_Memory_T_cell-CV-1|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.17e-04 | 197 | 57 | 4 | e59b47bccc781b2117196fe322efa87559c237c6 | |
| ToppCell | control-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.17e-04 | 197 | 57 | 4 | 8819db1550bf14566c6d33d97f7f83419e867ace | |
| ToppCell | severe-Myeloid-Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.20e-04 | 198 | 57 | 4 | 636878836678a0715550fa09f2e3dac11c4d73fe | |
| ToppCell | normal_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.20e-04 | 198 | 57 | 4 | e0e47cf65774191981840b22905b2094b95abe0f | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 1.20e-04 | 198 | 57 | 4 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-04 | 198 | 57 | 4 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 1.20e-04 | 198 | 57 | 4 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.22e-04 | 199 | 57 | 4 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Control-Control-Lymphocyte-B-Plasmablast|Control / Disease, condition lineage and cell class | 1.22e-04 | 199 | 57 | 4 | c11aa8bca3723a886e7082ae48bb922dd8396be4 | |
| ToppCell | BAL-Mild-cDC_1|Mild / Compartment, Disease Groups and Clusters | 1.22e-04 | 199 | 57 | 4 | c55181bdec8952b54198f0d4c9c5c84265b16572 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | 0a145172787f40d0fdaf21188d539ffaf7ece3e4 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 1.22e-04 | 199 | 57 | 4 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.22e-04 | 199 | 57 | 4 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | distal-2-mesenchymal-Airway_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.22e-04 | 199 | 57 | 4 | af226a6c50747dad9ca696463e715913b3ac17c0 | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.22e-04 | 199 | 57 | 4 | c2903b1a4b91e94bbdaa909bacefe901255cf248 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 89821a264e872ed53e08e9d3609d5cc5c314503e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | 1.24e-04 | 200 | 57 | 4 | d9e8a0d047d4403fb7265fde7448e23a7780785c | |
| ToppCell | distal-mesenchymal-Airway_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.24e-04 | 200 | 57 | 4 | f09eaa52e11262ec47f3dcb4d890e240eaaa2b3d | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.96e-04 | 88 | 57 | 3 | 3a92f76e4db86486cb265301e6056af791a11a63 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.77e-04 | 99 | 57 | 3 | eeb2d10170154c61717c38f85d0fbb61c4c48bb3 | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 4.72e-06 | 180 | 55 | 6 | 4776_UP | |
| Drug | adenophostin A | 5.73e-06 | 2 | 55 | 2 | ctd:C085029 | |
| Drug | Isocaffeine | 5.73e-06 | 2 | 55 | 2 | CID000001326 | |
| Drug | adenophostin B | 5.73e-06 | 2 | 55 | 2 | CID000656722 | |
| Drug | benzene 1,2,4-trisphosphate | 5.73e-06 | 2 | 55 | 2 | CID000192376 | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; PC3; HT_HG-U133A | 7.26e-06 | 194 | 55 | 6 | 4626_UP | |
| Drug | Pepstatin A [26305-03-3]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 8.39e-06 | 199 | 55 | 6 | 3264_UP | |
| Drug | 5-deoxy-5-fluoro-myo-inositol | 1.72e-05 | 3 | 55 | 2 | CID000195110 | |
| Drug | CHEBI:697555 | 3.43e-05 | 4 | 55 | 2 | CID009578246 | |
| Drug | AC1OAGFB | 4.29e-05 | 539 | 55 | 8 | CID006857345 | |
| Drug | XeC compound | 5.09e-05 | 84 | 55 | 4 | CID000005701 | |
| Drug | lavendustin A | 5.79e-05 | 171 | 55 | 5 | CID000003894 | |
| Drug | CNS 1145 | 6.91e-05 | 33 | 55 | 3 | CID000190902 | |
| Drug | IHC-64 | 6.91e-05 | 33 | 55 | 3 | CID000162753 | |
| Drug | AC1L1DXE | 8.24e-05 | 299 | 55 | 6 | CID000002548 | |
| Drug | AC1Q7BER | 8.54e-05 | 6 | 55 | 2 | CID000005702 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.00e-04 | 192 | 55 | 5 | 2523_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 1.00e-04 | 192 | 55 | 5 | 3400_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; HL60; HT_HG-U133A | 1.03e-04 | 193 | 55 | 5 | 2675_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.03e-04 | 193 | 55 | 5 | 3708_UP | |
| Drug | Methyldopa (L,-) [555-30-6]; Up 200; 19uM; HL60; HG-U133A | 1.08e-04 | 195 | 55 | 5 | 1619_UP | |
| Drug | Propafenone hydrochloride [34183-22-7]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 2871_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 1158_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 5703_UP | |
| Drug | Clofazimine [2030-63-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 3239_DN | |
| Drug | 0173570-0000 [211245-44-2]; Up 200; 1uM; PC3; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 3693_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 1163_UP | |
| Drug | Procainamide hydrochloride [614-39-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 5663_UP | |
| Drug | Bacitracin [1405-87-4]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 6488_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 3581_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.18e-04 | 199 | 55 | 5 | 6020_UP | |
| Drug | 3-F-InsP3 | 1.19e-04 | 7 | 55 | 2 | CID003035756 | |
| Drug | Br2BAPTA | 1.19e-04 | 7 | 55 | 2 | CID003081001 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 1.19e-04 | 7 | 55 | 2 | CID009547999 | |
| Drug | 9 mM of H | 1.59e-04 | 8 | 55 | 2 | CID000130464 | |
| Drug | basic copper carbonate | 1.59e-04 | 8 | 55 | 2 | CID000025503 | |
| Drug | Ns 004 | 1.59e-04 | 8 | 55 | 2 | CID000162750 | |
| Drug | F2 g | 1.59e-04 | 8 | 55 | 2 | CID006857713 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.26e-06 | 12 | 54 | 3 | DOID:1441 (implicated_via_orthology) | |
| Disease | Anoxic Encephalopathy | 3.29e-06 | 2 | 54 | 2 | C0003132 | |
| Disease | Brain Hypoxia | 3.29e-06 | 2 | 54 | 2 | C1527348 | |
| Disease | Anoxia of brain | 3.29e-06 | 2 | 54 | 2 | C0995195 | |
| Disease | Hypoxic Brain Damage | 3.29e-06 | 2 | 54 | 2 | C1140716 | |
| Disease | spinocerebellar ataxia type 5 (implicated_via_orthology) | 1.97e-05 | 4 | 54 | 2 | DOID:0050882 (implicated_via_orthology) | |
| Disease | grip strength measurement | 4.48e-04 | 350 | 54 | 5 | EFO_0006941 | |
| Disease | Lynch syndrome (is_implicated_in) | 8.84e-04 | 24 | 54 | 2 | DOID:3883 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLRASKTHRYQIWTT | 381 | P05156 | |
| KRHWNSQCRTTQSYV | 201 | P23560 | |
| STLCHILNLYRRATW | 131 | Q13363 | |
| QHLRSRTWYVQATCA | 146 | P84085 | |
| ITLDCQNIYTWKSRH | 86 | Q8N9N2 | |
| SKNRGRTTAHTKCWY | 641 | Q2TB18 | |
| RTTAHTKCWYEGNNR | 646 | Q2TB18 | |
| YVRLRHLCTNTWVTS | 386 | Q14571 | |
| YVRLRHLCTNTWIQS | 386 | Q14573 | |
| DILNWFKCTRHRISY | 56 | A6BM72 | |
| LQVKTCHLVRYWISA | 71 | Q7LDG7 | |
| SYVRLRHLCTNTWVH | 386 | Q14643 | |
| RILHRTDRWTYCINK | 2221 | Q15751 | |
| RVLVCAHRYTQVLWS | 136 | P26006 | |
| VTHRFSTKSWLSQVC | 346 | Q8IVT5 | |
| TVTEEQRRLLWCYHK | 1266 | Q9UHC1 | |
| VCWRSLSLKSHQRVS | 166 | A0A1B0GTH6 | |
| LSKLRTRHCTQAWAI | 396 | O75200 | |
| WHRRVNTTQKRYAIC | 111 | P36578 | |
| SKLRTRHCTQAWAIR | 406 | A6NHN6 | |
| RVTQIACGRWHTLAY | 296 | Q9UII4 | |
| WLTCQTEIRLRLHYS | 126 | Q9NPB8 | |
| HYRTFQSKCWQRVTR | 236 | Q6UXV0 | |
| SQKHWLSDRTYTCQV | 181 | P01854 | |
| SVRYTHQLCLLKWIS | 191 | A6NNE9 | |
| PEQWKSHRSYSCRVT | 76 | A0M8Q6 | |
| SWIRRTDNTTYIIKH | 281 | A8MVW5 | |
| WCSYVVTRTISCHVQ | 36 | Q96A84 | |
| HRNWCAYVVTRTVSC | 56 | Q9Y6C2 | |
| WRYVLVSTVRTCAKS | 2556 | Q9BYK8 | |
| NISTKAQCRAAHYRW | 1466 | O95180 | |
| RLSKLRTRHCTQAWA | 406 | E9PJ23 | |
| CHVQNTIIKWSERYT | 131 | Q5EG05 | |
| LSKLRTRHCTQAWAI | 411 | F8W1W9 | |
| YTTWKIRTSGECRHT | 361 | Q9UK39 | |
| HYRRTICSKVLVQWR | 711 | A8K8P3 | |
| LHYQTTKQNLWSCRR | 1161 | A8K8P3 | |
| TSVLRRAIWNYIHCV | 386 | P58004 | |
| ILCRNTYSVFKIHWL | 281 | Q9NPR9 | |
| KWRLSHCTVHRTDLY | 486 | Q6NW34 | |
| THSYEIRTTSRWRKH | 251 | Q9NVD3 | |
| VSIYCSMRKRSLSHW | 236 | A6NNN8 | |
| QCILQHTWTERKFYT | 1121 | Q9NZP6 | |
| SPALRWYRTSCHLTK | 21 | Q9NZ20 | |
| TKWVNSHLARVSCRI | 61 | Q01082 | |
| VQTLDCLRYWKATHR | 116 | P48736 | |
| WSCRKRITVEYLQHI | 4741 | Q63HN8 | |
| LNKHRSYEWSCRLVT | 26 | Q6ZRR5 | |
| ILKWVVSHQSCSRSS | 216 | A6PVC2 | |
| LYKHSKTTCLRWQSS | 656 | O15062 | |
| CWKVFSQSTYLIRHQ | 541 | Q9HBT7 | |
| RWQRSQISYKCHLVL | 1876 | Q15772 | |
| AISLWRHQCISYQKT | 276 | Q14159 | |
| GIHCIARKRSSSWSY | 1121 | Q9BY07 | |
| LFTHQSWQRCRTISL | 246 | Q3KNW5 | |
| TKWVNSHLARVSCRI | 61 | P11277 | |
| LKQTARSSSWHARYT | 1646 | Q14997 | |
| LVRSITCWTLSRYAH | 461 | Q92973 | |
| SEQWVVSAAHCYKTR | 111 | P35030 | |
| GISHYKWSQCRRESS | 211 | Q9BWM5 |